EGCG, quercetin, and kaempferol have all proven to be capable of augmenting the Nrf2 pathway, with this property proving to be an essential component among a few of these flavonoids’ antioxidant capabilities; thus, their use in PD serves as a promising means through which oxidative stress levels can be attenuated through multiple potent mechanisms. Here, NFE2L2 is linked to Parkinson disease.